Skyward Group has expanded Skyward Specialty’s Life Sciences insurance solution by leveraging Apollo’s Lloyd’s Syndicate 1969, to offer enhanced multinational placements for US-domiciled life sciences companies with international operations.
Skyward Group
is the unified specialty insurance organisation whose operating businesses include Skyward Specialty Insurance Group, Inc., a property and casualty specialist insurer, and Lloyd’s specialist Apollo.
This initiative marks the first strategic collaboration between Skyward Specialty and Apollo since the acquisition, worth $555 million, closed earlier this month
Andrew Robinson, Chairman and Chief Executive Officer, Skyward Group, commented, “The expansion of our Life Sciences product reflects the strength of our combined organisation and our ability to unlock new opportunities together. We quickly recognised the complementary capabilities across both organisations and saw this expansion as a natural first step in working together.”
He continued, “Apollo’s Lloyd’s platform and global licensing provides efficient access to support specialty risks on a global scale, and when paired with Skyward Specialty’s underwriting expertise, we can scale a high-quality portfolio while maintaining the discipline and technical focus that drive our sustainable, durable competitive advantage.”
